| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 65 |
| 1 | SACUBITRIL AND VALSARTAN | 48 |
| 2 | ASPIRIN | 36 |
| 3 | ASPIRIN 325 MG | 36 |
| 4 | ASPIRIN 81 MG | 36 |
| 5 | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 36 |
| 6 | ERGOCALCIFEROL | 34 |
| 7 | ACETAMINOPHEN | 27 |
| 8 | PANTOPRAZOLE | 26 |
| 9 | AMLODIPINE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASPIRIN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE BITARTRATE | 1 | 0.0323 |
| 1 | ALOE FEROX LEAF | 1 | 0.0055 |
| 2 | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 36 | 0.0040 |
| 3 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 4 | SETMELANOTIDE | 1 | 0.0035 |
| 5 | DINUTUXIMAB | 2 | 0.0023 |
| 6 | ETHACRYNIC ACID | 1 | 0.0018 |
| 7 | ISRADIPINE | 1 | 0.0018 |
| 8 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 9 | LIDOCAINE AND PRILOCAINE | 2 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 82 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 61 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 58 |
| 3 | Corticosteroid [EPC] | 57 |
| 4 | Benzodiazepine [EPC] | 45 |
| 5 | Osmotic Laxative [EPC] | 40 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 37 |
| 7 | Proton Pump Inhibitor [EPC] | 31 |
| 8 | Insulin Analog [EPC] | 30 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 2 | GLP-2 Analog [EPC] | 15 | 0.0011 |
| 3 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 4 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 5 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 6 | Sulfone [EPC] | 8 | 0.0007 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 8 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |